Gabriela G. Cezar

Health Technology

Consumer Services

Finance

Profile

Dr. Cezar co-founded at Stemina Biomarker Discovery in 2006.
Previously, she served as a senior principal scientist at Pfizer, working on global projects to incorporate stem cells in drug discovery and toxicology.
In her role at Pfizer, she also developed in vivo models (genetically modified mice) for target validation in multiple therapeutic areas.
Overall, she has extensive experience on integration and application of molecular technologies to pharmaceutical discovery and development.
She is also a assistant professor at the University of Wisconsin-Madison.
Dr. Cezar is a member of the Science Advisory Board of the Genetics Policy Institute, a leading nonprofit organization dedicated to establishing a positive legal framework to advance stem cell research, as well as other stem cell-related organizations and patient advocacy groups.
She is an internationally renowned invited speaker at numerous conferences.

Former positions of Gabriela G. Cezar

Companies	Position	End
Burrill LLC Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.	Corporate Officer/Principal	-
University of Wisconsin	Corporate Officer/Principal	-
PFIZER, INC.	Corporate Officer/Principal	-
Stemina Biomarker Discovery, Inc. Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI.	Founder	-

See the detail of Gabriela G. Cezar's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies